What is Alzheimer's disease?

Professor Kenneth Kosik defines Alzheimer's disease as a slowly progressing illness that deteriorates the brain and impairs many major cognitive functions.

Alzheimer’s disease affects elders. It affects their cognition. We generally think about Alzheimer’s affecting memory, however, the disease affects more than simply memory, it affects personality, it affects emotions. It’s a slow, insidious process that causes deterioration of the brain in which many cognitive functions become impaired. Now, that is a clinical definition, it is not the most precise definition. The most precise definition, actually, is the histological or pathological definition. And to actually diagnose Alzheimer’s and use that word we need to see senile plaques and neurofibrillary tangles under the microscope of the brain tissue.

alzheimer's, alzheimer, disease, precise definition, tangle, plaque, cognitive functions, cognition, deterioration, senile, senility, kenneth, kosik

Related Content

2028. Senile plaques and Alzheimer's disease

Professor Kenneth Kosik describes senile plaques, an extracellular collection of a-beta protein. It is one of the hallmarks of Alzheimer's disease.

  • ID: 2025
  • Type:
  • Source: G2C

2026. Testing for Alzheimer’s disease

Professor Kenneth Kosik explains that Alzheimer's disease is traditionally diagnosed by a physician taking a history and physical. In the near future, neuroimaging will provide an accurate diagnosis.

  • ID: 2025
  • Type:
  • Source: G2C

2033. Amyloid precursor protein and Alzheimer's disease

Professor Kenneth Kosik describes the relationship between the amyloid precursor protein (APP) and Alzheimer’s disease. APP mutations are linked to early-onset Alzheimer’s disease.

  • ID: 2025
  • Type:
  • Source: G2C

2029. Neurofibrillary tangles and Alzheimer's disease

Professor Kenneth Kosik discusses neurofibrillary tangles, which form inside a cell and are made up of a protein called tau. There is a strong relationship with plaques and amyloid deposition.

  • ID: 2025
  • Type:
  • Source: G2C

2337. Optical Imaging of Plaque Formation

Doctor Brian Bacskai discusses how his group uses optical image to record plaque formation in Alzheimer's-type mice.

  • ID: 2025
  • Type:
  • Source: G2C

2035. Acetylcholine and Alzheimer's disease

Professor Kenneth Kosik discusses the biochemistry of Alzheimer's disease in relation to acetylcholine and cholinergic deficiency.

  • ID: 2025
  • Type:
  • Source: G2C

2227. Alzheimer's disease

An overview of Alzheimer's disease-related content on Genes to Cognition Online.

  • ID: 2025
  • Type:
  • Source: G2C

2034. Mild Cognitive Impairment

Professor Kenneth Kosik discusses the relationship between mild cognitive impairment (MCI) and Alzheimer’s disease. MCI is a predictor of Alzheimer's disease.

  • ID: 2025
  • Type:
  • Source: G2C

1452. Tau Gene (MAPT)

Neurofibrillary tangles are bundles of tau proteins, which mark the tau gene (MAPT) as a strong candidate for Alzheimer’s disease.

  • ID: 2025
  • Type:
  • Source: G2C

2030. Tau protein and Alzheimer's disease

Professor Kenneth Kosik discusses the tau protein and its relationship to the neurofibrillary tangles found in Alzheimer's disease.

  • ID: 2025
  • Type:
  • Source: G2C